Grant: Discovery Grants Program - Individual
Université Laval
$48,000.00
Role of microRNAs in regulating endothelial cell functions
EF 2013-14
Résumé
The central hypothesis of this research program is that microRNAs (miRNAs) by regulating the expression of endothelial adhesion receptors such as E-selectin are major regulators of the adhesion of circulating cells to ECs. In particular, we hypothesize that miRNAs act in a feedback loop to repress the expression of E-selectin. We will pursue three specific objectives to test our hypothesis. 1) To ascertain the role of miRNAs in regulating cell adhesion and transendothelial cell migration. ECs will be transfected with mimics or inhibitors of miRNAs before being treated with inflammatory cytokines to induce the expression of E-selectin. Then, the adhesion of cells will be evaluated in static and dynamic conditions. Thereafter, the expression of miRNAs will be evaluated as well as their capacity to bind to the 3'UTR region of E-selectin mRNA. 2) To identify the signaling pathways triggering the expression of miRNAs. The involvement of the pathways known to regulate the expression of E-selectin in response to inflammatory cytokines will be evaluated. The approaches will rely on the use of chemical inhibitors, dominant negatives and siRNA-mediated knockdown of proteins of these pathways. 3) To investigate the mechanisms regulating the expression of miRNAs. The transcription level of pri-miRNAs will be determined. The processing of the pre-miRNAs and the stability of miRNAs will also be evaluated. The composition of the RNA-induced silencing (RISC) complex will be determined by appropriate cutting edge approaches in use in the lab. The role of phosphorylation of the RISC components will also be ascertained. Overall, this series of experiments will allow us to establish for the first time how miRNAs and miRNA-regulating pathways modulate E-selectin expression to modulate the adhesion of circulating cells to ECs. In corollary, our innovative research program will open new avenues in understanding the role of miRNAs in cell-cell adhesion and cell migration. Ultimately, our results will help to better understand inflammation, immunity and cancer.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
227502-2011
Name nom
Huot, Jacques
Department département
Médecine, Faculté de
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2011
Award amount
48000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5108
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell movement
Research subject fr
Mouvements cellulaires
Partie
3
Nb partie
5
Application title
Role of microRNAs in regulating endothelial cell functions
Keyword
NSERC
Application summary
The central hypothesis of this research program is that microRNAs (miRNAs) by regulating the expression of endothelial adhesion receptors such as E-selectin are major regulators of the adhesion of circulating cells to ECs. In particular, we hypothesize that miRNAs act in a feedback loop to repress the expression of E-selectin. We will pursue three specific objectives to test our hypothesis. 1) To ascertain the role of miRNAs in regulating cell adhesion and transendothelial cell migration. ECs will be transfected with mimics or inhibitors of miRNAs before being treated with inflammatory cytokines to induce the expression of E-selectin. Then, the adhesion of cells will be evaluated in static and dynamic conditions. Thereafter, the expression of miRNAs will be evaluated as well as their capacity to bind to the 3'UTR region of E-selectin mRNA. 2) To identify the signaling pathways triggering the expression of miRNAs. The involvement of the pathways known to regulate the expression of E-selectin in response to inflammatory cytokines will be evaluated. The approaches will rely on the use of chemical inhibitors, dominant negatives and siRNA-mediated knockdown of proteins of these pathways. 3) To investigate the mechanisms regulating the expression of miRNAs. The transcription level of pri-miRNAs will be determined. The processing of the pre-miRNAs and the stability of miRNAs will also be evaluated. The composition of the RNA-induced silencing (RISC) complex will be determined by appropriate cutting edge approaches in use in the lab. The role of phosphorylation of the RISC components will also be ascertained. Overall, this series of experiments will allow us to establish for the first time how miRNAs and miRNA-regulating pathways modulate E-selectin expression to modulate the adhesion of circulating cells to ECs. In corollary, our innovative research program will open new avenues in understanding the role of miRNAs in cell-cell adhesion and cell migration. Ultimately, our results will help to better understand inflammation, immunity and cancer.